Rivastigmine
Exelon
Cholinesterase Inhibitor
NADAC/unit
$0.1497
No Shortage
Tier 1: 150.2%
13 Manufacturers
47 ANDAs
Rivastigmine slows cognitive decline in Alzheimer's disease by preserving acetylcholine levels.
vs. brand Exelon: Generic saves up to 99% per unit
Generic Manufacturers
ALEMBIC PHARMACEUTICALS LTDAMNEAL PHARMACEUTICALS OF NEW YORK LLCAUROBINDO PHARMA LTDBRECKENRIDGE PHARMACEUTICAL INCCADILA PHARMACEUTICALS LTDCHARTWELL RX SCIENCES LLCDR REDDYS LABORATORIES INCMACLEODS PHARMACEUTICALS LTDMYLAN TECHNOLOGIES INCORBION PHARMACEUTICALS PRIVATE LTDSANDOZ INCWATSON LABORATORIES INCYICHANG HUMANWELL PHARMACEUTICAL CO LTDZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
